Study of CD160 expression in B-chronic Lymphocytic Leukemia
A Mohammed, MM Azab - Zagazig University Medical Journal, 2022 - journals.ekb.eg
B-cell lymphoproliferative disorders (B-CLPD) are a biologically heterogeneous group of
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …
malignant diseases characterized by accumulation of mature B lymphocytes in the bone …
[HTML][HTML] Evaluation of CD160 and CD200 expression as differentiating markers between chronic lymphocytic leukemia and other mature B-cell neoplasms
WA El-Neanaey, RS Swelem, OM Ghallab… - … -Oncology and Stem …, 2020 - ncbi.nlm.nih.gov
Background: The present work aimed to investigate the expression of CD160/CD200 in CLL
and other mature B-cell neoplasms (MBN) and their use as an additional diagnostic tool for …
and other mature B-cell neoplasms (MBN) and their use as an additional diagnostic tool for …
Expression patterns of CD200 and CD148 in leukemic B-cell chronic lymphoproliferative disorders and their potential value in differential diagnosis
L Fan, Y Miao, YJ Wu, Y Wang, R Guo… - Leukemia & …, 2015 - Taylor & Francis
Different combinations of biomarkers analyzed by flow cytometry are critical for the accurate
diagnosis of leukemic B-cell chronic lymphoproliferative disorders (B-CLPDs). We …
diagnosis of leukemic B-cell chronic lymphoproliferative disorders (B-CLPDs). We …
[HTML][HTML] The Contribution of CD148, CD180 and CD200 Combination in the Diagnosis of Chronic B-Cell Lymphoproliferative Disorders
L Miguet, C Mayeur-Rousse, A Eischen, AC Galoisy… - Blood, 2021 - Elsevier
Introduction: B-cell immunophenotype could be swiftly assessed by flow cytometry on blood
samples or bone marrow aspirate specimens. It provides crucial information later refined …
samples or bone marrow aspirate specimens. It provides crucial information later refined …
Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders
E Cabezudo, P Carrara, R Morilla, E Matutes - Haematologica, 1999 - haematologica.org
BACKGROUND AND OBJECTIVE: Distinction between B-cell chronic leukemias can be
difficult due to overlap in cell morphology and immunologic features. We investigated, by …
difficult due to overlap in cell morphology and immunologic features. We investigated, by …
Combination of CD 160 and CD 200 as a useful tool for differential diagnosis between chronic lymphocytic leukemia and other mature B‐cell neoplasms
JF Lesesve, S Tardy, B Frotscher… - … journal of laboratory …, 2015 - Wiley Online Library
Introduction Chronic lymphocytic leukemia is usually diagnosed through the characteristic
morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical …
morphology/immunophenotype of the lymphocytes, but some CLL cases remain atypical …
[HTML][HTML] CD 200–A useful marker in chronic B lymphoprolipherative disorders
A Iova, A Vlădăreanu, H Bumbea, M Begu… - Journal of Medicine …, 2012 - ncbi.nlm.nih.gov
Background: The diagnosis and management of the patients with chronic
lymphoproliferative diseases have become dependent on immunological criteria. Flow …
lymphoproliferative diseases have become dependent on immunological criteria. Flow …
[HTML][HTML] The potential differential diagnosis value and clinical significance of CD35 expression in B-chronic lymphoproliferative disorders
Y Shi, L Liu, H Yang, X Chen, Y Wang… - Annals of …, 2021 - ncbi.nlm.nih.gov
Background Flow cytometry for immunophenotyping is the main method for diagnosing
chronic lymphocytic leukemia (CLL). Differential diagnosis between CLL and other B …
chronic lymphocytic leukemia (CLL). Differential diagnosis between CLL and other B …
High levels of CD160 expression up-regulated counts of chronic lymphocytic leukemia cells and were associated with other clinical parameters in Chinese patients …
ZH Zhang, S Chen, S Chen, Y Liu, JH Qu - Leukemia & Lymphoma, 2015 - Taylor & Francis
Chronic lymphocytic leukemia (CLL) is characterized by the accumulation of monoclonal B
cells expressing CD19, CD5 and CD23 together with low surface expression of B-cell …
cells expressing CD19, CD5 and CD23 together with low surface expression of B-cell …
CD200 expression in B-cell chronic lymphoproliferative disorders
Background Flow cytometry immunophenotyping (FCIP) is used for rapid, specific diagnosis
of B-chronic lymphoproliferative disorders (BCLPDs). However, cases may deviate from the …
of B-chronic lymphoproliferative disorders (BCLPDs). However, cases may deviate from the …